vimarsana.com
Home
Live Updates
Monoclonal antibody shows promise in slowing progression of ALS : vimarsana.com
Monoclonal antibody shows promise in slowing progression of ALS
New research reveals a type of monoclonal antibody already tested in certain forms of cancer may be a promising treatment in stopping the progression of amyotrophic lateral sclerosis, or ALS, a fatal neurodegenerative disease.
Related Keywords
Oregon ,
United States ,
Lawrence Steinman ,
Randall Woltjer ,
Shanuf Roemer ,
Katie Emberley ,
Lisa Ryner ,
Michael Leviten ,
Alina Bogachuk ,
Lily Ramsey ,
Audie Chiot ,
Gissellea Jimenez ,
Dillon Brownell ,
Bahareh Ajami ,
Dennis Dickson ,
School Of Medicine ,
Proceedings Of The National Academy Sciences ,
Stanford University ,
Oregon Health Science University ,
Drug Administration ,
Oregon Health ,
Science University ,
National Academy ,
Mayo Clinic ,
Pasithea Therapeutics ,
Immunotherapy ,
Amyotrophic Lateral Sclerosis ,
Ntibody ,
Rain ,
Dancer ,
High Throughput Screening ,
Immune System ,
Mmunology ,
Icrobiology ,
Monoclonal Antibody ,
Ouse Model ,
Multiple Sclerosis ,
Eurodegenerative Disease ,
Neuroscience ,
Mh ,
Protein ,
Research ,
Clerosis ,
vimarsana.com © 2020. All Rights Reserved.